Novavax’s COVID-19 vaccine ‘highly’ effective against UK variant
Vaccine found to have an overall vaccine efficacy of 89.7% in Phase III trial
Read More
Tag: UK variant
Gilead’s Veklury should be effective against COVID-19 variants
Company has completed genetic analysis for UK and South African variants
Read More
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
